Daniel Ventura

1.0k total citations
13 papers, 757 citations indexed

About

Daniel Ventura is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Daniel Ventura has authored 13 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Experimental and Cognitive Psychology and 4 papers in Psychiatry and Mental health. Recurrent topics in Daniel Ventura's work include Treatment of Major Depression (5 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Epilepsy research and treatment (3 papers). Daniel Ventura is often cited by papers focused on Treatment of Major Depression (5 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Epilepsy research and treatment (3 papers). Daniel Ventura collaborates with scholars based in United States, India and Austria. Daniel Ventura's co-authors include Robert J. Bielski, Wattanaporn Abramowitz, Andrew Korotzer, Graham J. Emslie, Stavros Tourkodimitris, Antonia Periclou, Robert L. Findling, Jeffrey M. Jonas, Khalil G. Saikali and Karen Dineen Wagner and has published in prestigious journals such as Journal of the American Academy of Child & Adolescent Psychiatry, Clinical Pharmacology & Therapeutics and The Journal of Clinical Psychiatry.

In The Last Decade

Daniel Ventura

13 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Ventura United States 10 322 286 213 146 85 13 757
Judith C. Kando United States 15 264 0.8× 741 2.6× 135 0.6× 60 0.4× 99 1.2× 40 1.2k
T. Sasaki Japan 13 194 0.6× 239 0.8× 149 0.7× 61 0.4× 224 2.6× 23 824
Michael Murphy United States 13 174 0.5× 133 0.5× 72 0.3× 52 0.4× 75 0.9× 32 725
Murray Rosenthal United States 15 188 0.6× 230 0.8× 101 0.5× 352 2.4× 71 0.8× 23 899
Matthew Macaluso United States 14 372 1.2× 209 0.7× 142 0.7× 98 0.7× 133 1.6× 64 902
Peter F.J. Schulte Netherlands 17 107 0.3× 799 2.8× 211 1.0× 83 0.6× 63 0.7× 47 1.1k
A. Fiorentini Italy 14 150 0.5× 432 1.5× 162 0.8× 63 0.4× 99 1.2× 31 841
Stephanie Feldman United States 24 209 0.6× 585 2.0× 178 0.8× 66 0.5× 150 1.8× 48 1.2k
Maju Mathew Koola United States 19 197 0.6× 365 1.3× 153 0.7× 40 0.3× 120 1.4× 60 978
Stefan Unterecker Germany 14 235 0.7× 372 1.3× 101 0.5× 64 0.4× 64 0.8× 71 818

Countries citing papers authored by Daniel Ventura

Since Specialization
Citations

This map shows the geographic impact of Daniel Ventura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ventura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ventura more than expected).

Fields of papers citing papers by Daniel Ventura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ventura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ventura. The network helps show where Daniel Ventura may publish in the future.

Co-authorship network of co-authors of Daniel Ventura

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ventura. A scholar is included among the top collaborators of Daniel Ventura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ventura. Daniel Ventura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Emslie, Graham J., Daniel Ventura, Andrew Korotzer, & Stavros Tourkodimitris. (2009). Escitalopram in the Treatment of Adolescent Depression: A Randomized Placebo-Controlled Multisite Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 48(7). 721–729. 142 indexed citations
2.
Wagner, Karen Dineen, Jeffrey M. Jonas, Robert L. Findling, Daniel Ventura, & Khalil G. Saikali. (2006). A Double-Blind, Randomized, Placebo-Controlled Trial of Escitalopram in the Treatment of Pediatric Depression. Journal of the American Academy of Child & Adolescent Psychiatry. 45(3). 280–288. 144 indexed citations
3.
Periclou, Antonia, Daniel Ventura, Narsing A. Rao, & Wattanaporn Abramowitz. (2006). Pharmacokinetic study of memantine in healthy and renally impaired subjects. Clinical Pharmacology & Therapeutics. 79(1). 134–143. 81 indexed citations
4.
Ventura, Daniel, Edward P. Armstrong, Grant H. Skrepnek, & M. Haim Erder. (2006). Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Current Medical Research and Opinion. 23(2). 245–250. 48 indexed citations
5.
Rao, Niranjan, Thomas T. Chou, Daniel Ventura, & Wattanaporn Abramowitz. (2005). Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: A single-center, multiple-dose, open-label study. Clinical Therapeutics. 27(10). 1596–1606. 24 indexed citations
6.
Bielski, Robert J., et al.. (2004). A Double-Blind Comparison of Escitalopram and Venlafaxine Extended Release in the Treatment of Major Depressive Disorder. The Journal of Clinical Psychiatry. 65(9). 1190–1196. 141 indexed citations
7.
Periclou, Antonia, et al.. (2004). Lack of Pharmacokinetic or Pharmacodynamic Interaction Between Memantine and Donepezil. Annals of Pharmacotherapy. 38(9). 1389–1394. 66 indexed citations
8.
Bielski, Robert J., Daniel Ventura, Chia-Jung Chang, & Andrew Korotzer. (2003). P.1.207 Double-blind comparison of escitalopram and venlafaxine XR in the treatment of major depressive disorder. European Neuropsychopharmacology. 13. S263–S263. 10 indexed citations
9.
Periclou, Antonia, et al.. (2003). P.4.030 Pharmacokinetic study of memantine and donepezil in healthy young subjects. European Neuropsychopharmacology. 13. S398–S398. 3 indexed citations
10.
Strayer, David R., et al.. (1996). Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:PolyC12U in the treatment of HIV infection. European Journal of Clinical Microbiology & Infectious Diseases. 15(7). 580–587. 74 indexed citations
11.
Carter, William A., Daniel Ventura, David E. Shapiro, et al.. (1991). Mismatched double-stranded RNA, ampligen (poly(I) : poly(C12U)), demonstrates antiviral and immunostimulatory activities in HIV disease. International Journal of Immunopharmacology. 13. 69–76. 18 indexed citations
12.
Klausner, Mark A., Daniel Ventura, J.B. Coelho, et al.. (1988). Cardioselectivity of Cetamolol Compared With Atenolol and Nadolol. The Journal of Clinical Pharmacology. 28(6). 495–504. 2 indexed citations
13.
Coelho, J.B., et al.. (1985). Dynamics of beta‐adrenoceptor blockade with cetamolol.. British Journal of Clinical Pharmacology. 19(4). 411–416. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026